Vitamin D may cut cancer risk
The researchers believe that vitamin D could prevent up to half of the cases of breast cancer and two-thirds of the cases of colorectal cancer in the US.
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.